Seminars in oncology

Keyphrases

Publications

2024

Giovanni Corso, Nicola Fusco, Elena Guerini-Rocco, Maria Cristina Leonardi, Carmen Criscitiello, Paola Zagami, Eleonora Nicolò, Giovanni Mazzarol, Carlo La Vecchia, Filippo Pesapane, Cristina Zanzottera, Paolo Tarantino, Salvatore Petitto, Beatrice Bianchi, Giulia Massari, Anthony Boato, Andrea Sibilio, Andrea Polizzi, Giuseppe Curigliano, Alessandra Margherita De Scalzi, Federica Lauria, Bernardo Bonanni, Monica Marabelli, Anna Rotili, Luca Nicosia, Adriana Albini, Mariarosaria Calvello, Rita A Mukhtar, Mark E Robson, Virgilio Sacchini, Gad Rennert, Viviana Galimberti, Paolo Veronesi, Francesca Magnoni
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment. Seminars in oncology (2024)
Laura Basterretxea Badiola, Nuria Lainez Milagro, Diego Cacho Lavín, Sandra López Peraita, Mikel Arruti Ibarbia, Mireia Martínez Kareaga, Teresa de Portugal Fernández Del Rivero, Diego Soto de Prado Otero, Valentín Alija López, Carlos Álvarez Fernández, Alejandra Lacalle Emborujo, Irene Gil Arnaiz, Ricardo Fernández Rodríguez, Naiara Sagastibeltza, Ignacio Duran, null null
RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain. Seminars in oncology (2024)
Paula Sobrini-Morillo, Christine Ravot, Chloé Herlédan, Carmen Sánchez-Castellano, Alfonso J Cruz-Jentoft, Claire Falandry
Real-world experience with CDK4-6 inhibition in the old and oldest old with a diagnosis of breast cancer. Seminars in oncology (2024)
Harshraj Leuva, George Moran, Nader Jamaleddine, Mina Meseha, Mengxi Zhou, Yunju Im, Ta-Chueh Melody Rosenberg, Yeun-Hee Anna Park, Carol Luhrs, Susan E Bates, Izak Faiena
Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer. Seminars in oncology (2024)
Michael R Bishop, Gary E Kay
CAR T-cell therapy: A collaboration between authorized treatment centers and community oncologists. Seminars in oncology (2024)
Tito Fojo
Seminars in oncology 50th anniversary. Seminars in oncology (2024)
Ian S Goldlust, Elena Guidice, Jung-Min Lee
PARP inhibitors in ovarian cancer. Seminars in oncology (2024)
Orsi Giulia, Bandiera Alessandro, Carretta Angelo, Migliori Paolo, Chavez Rosa, Macchini Marina, Peretti Umberto, Carconi Catia, Veronesi Giulia, Falconi Massimo, Reni Michele
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease. Seminars in oncology (2024)
Demi Wekking, Matteo Lambertini, Mariele Dessì, Nerina Denaro, Fabio Bardanzellu, Ornella Garrone, Mario Scartozzi, Cinzia Solinas
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety. Seminars in oncology (2024)

volume 51, number 1-2, 2024

Ian S Goldlust, Elena Guidice, Jung-Min Lee
PARP inhibitors in ovarian cancer. Seminars in oncology 51 (1-2) (2024)
Ian S Goldlust, Elena Guidice, Jung-Min Lee
PARP inhibitors in ovarian cancer. Seminars in oncology 51 (1-2) (2024)
Ian S Goldlust, Elena Guidice, Jung-Min Lee
PARP inhibitors in ovarian cancer. Seminars in oncology 51 (1-2) (2024)
Tito Fojo
Seminars in oncology 50th anniversary. Seminars in oncology 51 (1-2) (2024)
Ian S Goldlust, Elena Guidice, Jung-Min Lee
PARP inhibitors in ovarian cancer. Seminars in oncology 51 (1-2) (2024)
Tito Fojo
Seminars in oncology 50th anniversary. Seminars in oncology 51 (1-2) (2024)
Ian S Goldlust, Elena Guidice, Jung-Min Lee
PARP inhibitors in ovarian cancer. Seminars in oncology 51 (1-2) (2024)

volume 51, number 3-4, 2024

Laura Basterretxea Badiola, Nuria Lainez Milagro, Diego Cacho Lavín, Sandra López Peraita, Mikel Arruti Ibarbia, Mireia Martínez Kareaga, Teresa de Portugal Fernández Del Rivero, Diego Soto de Prado Otero, Valentín Alija López, Carlos Álvarez Fernández, Alejandra Lacalle Emborujo, Irene Gil Arnaiz, Ricardo Fernández Rodríguez, Juan Verdún-Aguilar, Naiara Sagastibeltza, Ignacio Duran, null null
RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain. Seminars in oncology 51 (3-4) (2024)
Orsi Giulia, Bandiera Alessandro, Carretta Angelo, Migliori Paolo, Chavez Rosa, Macchini Marina, Peretti Umberto, Carconi Catia, Veronesi Giulia, Falconi Massimo, Reni Michele
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease. Seminars in oncology 51 (3-4) (2024)
Paula Sobrini-Morillo, Christine Ravot, Chloé Herlédan, Carmen Sánchez-Castellano, Alfonso J Cruz-Jentoft, Claire Falandry
Real-world experience with CDK4-6 inhibition in the old and oldest old with a diagnosis of breast cancer. Seminars in oncology 51 (3-4) (2024)
Michael R Bishop, Gary E Kay
CAR T-cell therapy: A collaboration between authorized treatment centers and community oncologists. Seminars in oncology 51 (3-4) (2024)
Laura Basterretxea Badiola, Nuria Lainez Milagro, Diego Cacho Lavín, Sandra López Peraita, Mikel Arruti Ibarbia, Mireia Martínez Kareaga, Teresa de Portugal Fernández Del Rivero, Diego Soto de Prado Otero, Valentín Alija López, Carlos Álvarez Fernández, Alejandra Lacalle Emborujo, Irene Gil Arnaiz, Ricardo Fernández Rodríguez, Juan Verdún-Aguilar, Naiara Sagastibeltza, Ignacio Duran, null null
RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain. Seminars in oncology 51 (3-4) (2024)
Harshraj Leuva, George Moran, Nader Jamaleddine, Mina Meseha, Mengxi Zhou, Yunju Im, Ta-Chueh Melody Rosenberg, Yeun-Hee Anna Park, Carol Luhrs, Susan E Bates, Izak Faiena
Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer. Seminars in oncology 51 (3-4) (2024)
Giovanni Corso, Nicola Fusco, Elena Guerini-Rocco, Maria Cristina Leonardi, Carmen Criscitiello, Paola Zagami, Eleonora Nicolò, Giovanni Mazzarol, Carlo La Vecchia, Filippo Pesapane, Cristina Zanzottera, Paolo Tarantino, Salvatore Petitto, Beatrice Bianchi, Giulia Massari, Anthony Boato, Andrea Sibilio, Andrea Polizzi, Giuseppe Curigliano, Alessandra Margherita De Scalzi, Federica Lauria, Bernardo Bonanni, Monica Marabelli, Anna Rotili, Luca Nicosia, Adriana Albini, Mariarosaria Calvello, Rita A Mukhtar, Mark E Robson, Virgilio Sacchini, Gad Rennert, Viviana Galimberti, Paolo Veronesi, Francesca Magnoni
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment. Seminars in oncology 51 (3-4) (2024)
Harshraj Leuva, George Moran, Nader Jamaleddine, Mina Meseha, Mengxi Zhou, Yunju Im, Ta-Chueh Melody Rosenberg, Yeun-Hee Anna Park, Carol Luhrs, Susan E Bates, Izak Faiena
Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer. Seminars in oncology 51 (3-4) (2024)

volume 50, number 6, 2024

Demi Wekking, Matteo Lambertini, Mariele Dessì, Nerina Denaro, Fabio Bardanzellu, Ornella Garrone, Mario Scartozzi, Cinzia Solinas
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety. Seminars in oncology 50 (6) (2024)
Demi Wekking, Matteo Lambertini, Mariele Dessì, Nerina Denaro, Fabio Bardanzellu, Ornella Garrone, Mario Scartozzi, Cinzia Solinas
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety. Seminars in oncology 50 (6) (2024)

volume 51, number 1-2, 2023

Meredith LaRose, Gulam A Manji, Susan E Bates
Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer. Seminars in oncology 51 (1-2) (2023)
Meredith LaRose, Gulam A Manji, Susan E Bates
Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer. Seminars in oncology 51 (1-2) (2023)
Meredith LaRose, Gulam A Manji, Susan E Bates
Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer. Seminars in oncology 51 (1-2) (2023)

volume 50, number 1-2, 2023

Tito Fojo
The flaws in assessing and reporting the toxicities of oral targeted therapies: Everolimus as an example. Seminars in oncology 50 (1-2) (2023)

volume 50, number 6, 2023

Joshua Shain, Alissa Michel, Michael S May, Lindor Qunaj, Wafaa El-Sadr, Wendy K Chung, Paul S Appelbaum, Judith S Jacobson, Jessica Justman, Alfred I Neugut
Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data. Seminars in oncology 50 (6) (2023)
Joshua Shain, Alissa Michel, Michael S May, Lindor Qunaj, Wafaa El-Sadr, Wendy K Chung, Paul S Appelbaum, Judith S Jacobson, Jessica Justman, Alfred I Neugut
Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data. Seminars in oncology 50 (6) (2023)
Serafina Martella, Minke Lucas, Michele Porcu, Laura Perra, Nerina Denaro, Andrea Pretta, Giulia Deias, Karen Willard-Gallo, Hector Soto Parra, Luca Saba, Mario Scartozzi, Demi Wekking, Marleen Kok, Marco Maria Aiello, Cinzia Solinas
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects. Seminars in oncology 50 (6) (2023)
Joshua Shain, Alissa Michel, Michael S May, Lindor Qunaj, Wafaa El-Sadr, Wendy K Chung, Paul S Appelbaum, Judith S Jacobson, Jessica Justman, Alfred I Neugut
Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data. Seminars in oncology 50 (6) (2023)
Serafina Martella, Minke Lucas, Michele Porcu, Laura Perra, Nerina Denaro, Andrea Pretta, Giulia Deias, Karen Willard-Gallo, Hector Soto Parra, Luca Saba, Mario Scartozzi, Demi Wekking, Marleen Kok, Marco Maria Aiello, Cinzia Solinas
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects. Seminars in oncology 50 (6) (2023)
Joshua Shain, Alissa Michel, Michael S May, Lindor Qunaj, Wafaa El-Sadr, Wendy K Chung, Paul S Appelbaum, Judith S Jacobson, Jessica Justman, Alfred I Neugut
Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data. Seminars in oncology 50 (6) (2023)

volume 49, number 6, 2023

Irene Persano, Elena Parlagreco, Anna La Salvia, Marco Audisio, Marco Volante, Consuelo Buttigliero, Giorgio Vittorio Scagliotti, Maria Pia Brizzi
Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review. Seminars in oncology 49 (6) (2023)
David Smith, Micaela Raices, Federico Cayol, Franco Corvatta, Lucas Caram, Agustín Dietrich
Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy? Seminars in oncology 49 (6) (2023)
Tito Fojo
The challenges of selecting cancer medicines for the WHO Essential Medicines List with the elephant in the room: A path forward. Seminars in oncology 49 (6) (2023)
Naoki Kawakami, Hiroaki Saito, Susumu Takahashi, Shinpei Kajie, Rina Kato, Kazuhiro Shimaya, Yoko Wakai, Kazuhito Saito, Mai Sakashita
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review. Seminars in oncology 49 (6) (2023)
Natasha A Roberts, Elizabeth Ahern, Anita Pelecanos, Harry Gasper, Bryan Chan, Zarnie Lwin
From doctors to ancillary staff: Regional and metropolitan cancer workforce perceptions and distress resulting from COVID-19 pandemic adaptations. Seminars in oncology 49 (6) (2023)
Irene Persano, Elena Parlagreco, Anna La Salvia, Marco Audisio, Marco Volante, Consuelo Buttigliero, Giorgio Vittorio Scagliotti, Maria Pia Brizzi
Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review. Seminars in oncology 49 (6) (2023)
Naoki Kawakami, Hiroaki Saito, Susumu Takahashi, Shinpei Kajie, Rina Kato, Kazuhiro Shimaya, Yoko Wakai, Kazuhito Saito, Mai Sakashita
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review. Seminars in oncology 49 (6) (2023)
David Smith, Micaela Raices, Federico Cayol, Franco Corvatta, Lucas Caram, Agustín Dietrich
Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy? Seminars in oncology 49 (6) (2023)
Nerina Denaro, Ornella Garrone, Annamaria Morelli, Benedetta Pellegrino, Marco Carlo Merlano, Denise Vacca, Josie Pearce, Daniele Farci, Antonino Musolino, Mario Scartozzi, Chiara Tommasi, Cinzia Solinas
A narrative review of the principal glucocorticoids employed in cancer. Seminars in oncology 49 (6) (2023)
Natasha A Roberts, Elizabeth Ahern, Anita Pelecanos, Harry Gasper, Bryan Chan, Zarnie Lwin
From doctors to ancillary staff: Regional and metropolitan cancer workforce perceptions and distress resulting from COVID-19 pandemic adaptations. Seminars in oncology 49 (6) (2023)
Yoshan Moodley, Kumeren Govender, Jacqueline van Wyk, Seren Reddy, Yuming Ning, Steven Wexner, Laura Stopforth, Shona Bhadree, Vasudevan Naidoo, Shakeel Kader, Shalen Cheddie, Alfred I Neugut, Ravi P Kiran
Predictors of treatment refusal in patients with colorectal cancer: A systematic review. Seminars in oncology 49 (6) (2023)
Nerina Denaro, Ornella Garrone, Annamaria Morelli, Benedetta Pellegrino, Marco Carlo Merlano, Denise Vacca, Josie Pearce, Daniele Farci, Antonino Musolino, Mario Scartozzi, Chiara Tommasi, Cinzia Solinas
A narrative review of the principal glucocorticoids employed in cancer. Seminars in oncology 49 (6) (2023)
Yoshan Moodley, Kumeren Govender, Jacqueline van Wyk, Seren Reddy, Yuming Ning, Steven Wexner, Laura Stopforth, Shona Bhadree, Vasudevan Naidoo, Shakeel Kader, Shalen Cheddie, Alfred I Neugut, Ravi P Kiran
Predictors of treatment refusal in patients with colorectal cancer: A systematic review. Seminars in oncology 49 (6) (2023)
Irene Persano, Elena Parlagreco, Anna La Salvia, Marco Audisio, Marco Volante, Consuelo Buttigliero, Giorgio Vittorio Scagliotti, Maria Pia Brizzi
Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review. Seminars in oncology 49 (6) (2023)